关键词：深度烧伤;临床研究;皮片移植

Imogen Stamford

Research has shown that use of continuous glucose monitoring (CGM) is associated with improved time in range, improved HbA1c, and decreased risk of long-term complications secondary to type 1 diabetes. There are, however, several barriers that can lead to discontinuation of CGM, including pain, skin reactions, concerns around accuracy, sensor loss, interference with daily activity, and alarm fatigue. This review paper will outline the impact of decision fatigue and alarm fatigue in children and young people using CGM.

Citation: Stamford I (2022) CGM for children and young people with type 1 diabetes: NICE criteria and effects of decision fatigue and alarm fatigue. for Children & Young People Diabetes Care 12: [Early view publication]

Article points

1. While the advantages of continuous glucose monitoring (CGM) are well recognised, as practitioners it is important to be aware of the implications of CGM use.

2. People with diabetes can never have a day without checking and responding to ever-changing glucose levels, which puts them at an increased risk of developing decision fatigue.

3. It is important for practitioners to support patients in creating balance between setting alarm limits that are narrow enough to ensure patient safety, but not so narrow that alarms will be repeatedly triggered can lead to the risk of alarms being ignored.

Key words

- Alarm fatigue

- Continuous glucose monitoring

- Decision fatigue

- Type 1 diabetes

Author

Imogen Stamford, Paediatric Diabetes Specialist Nurse, Oxford University Hospitals NHS Foundation Trust

Journal Pre-proof

Epidermal stem cell derived exosomes alleviate excessive autophagy induced endothelial cell apoptosis by delivering miR200b-3p to diabetic wounds. Hailin Xu, Hao Yang, Zhiyong Wang, Qizhi Tang, Xiaoling Cao, Chufen Chen, Yunxian Dong, Zhongye Xu, Dongming Lv, Yanchao Rong, Miao Chen, Bing Tang, Wuguo Deng, Jiayuan Zhu, Zhicheng Hu

PII:

S0022-202X(23)02951-2

DOI:

https://doi.org/10.1016/j.jid.2023.08.030

Reference:

JID 4023

To appear in:

The Journal of Investigative Dermatology

Received Date: 2 December 2022

Revised Date: 3 August 2023

Accepted Date: 30 August 2023

Please cite this article as: Xu H, Yang H, Wang Z, Tang Q, Cao X, Chen C, Dong Y, Xu Z, Lv D, Rong Y, Chen M, Tang B, Deng W, Zhu J, Hu Z, Epidermal stem cell derived exosomes alleviate excessive autophagy induced endothelial cell apoptosis by delivering miR200b-3p to diabetic wounds., The Journal of Investigative Dermatology (2023), doi: https://doi.org/10.1016/j.jid.2023.08.030.

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

© 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.

Epidermal stem cell derived exosomes alleviate excessive autophagy induced endothelial cell apoptosis by delivering

miR200b-3p to diabetic wounds.

Hailin Xu1, #, Hao Yang1, #, Zhiyong Wang1, # , Qizhi Tang2, #, Xiaoling Cao1 , Chufen Chen1 , Yunxian

Dong1 , Zhongye Xu1 , Dongming Lv 1 , Yanchao Rong1 , Miao Chen2 , Bing Tang1 , Wuguo Deng3 *,

Jiayuan Zhu1 *, Zhicheng Hu1, *

Epidermal stem cell derived exosomes alleviate excessive autophagy induced endothelial cell apoptosis by delivering miR200b-3p to diabetic wounds.

Hailin Xu1, #, Hao Yang1, #, Zhiyong Wang1, # , Qizhi Tang2, #, Xiaoling Cao1 , Chufen Chen1 , Yunxian Dong1 , Zhongye Xu1 , Dongming Lv 1 , Yanchao Rong1 , Miao Chen2 , Bing Tang1 , Wuguo Deng3 *, Jiayuan Zhu1 *, Zhicheng Hu1, *

1 First Affiliated Hospital of Sun Yat-sen University, Burn department, Guangzhou 51080, China.

2 Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine; Affiliated Nanhai Hospital of Traditional Chinese Medicine of Jinan University, Foshan 528200,

3 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou 510080, China.

#These authors contribute the same to the study.

*Corresponding author:

Zhicheng Hu, First Affiliated Hospital of Sun Yat-sen University, Burn department, Guangzhou, China (E-mail: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。).

ORCIDs：

Hailin Xu, http://orcid.org/0000-0002-6448-7343

Hao Yang, http://orcid.org/0000-0002-5388-5039

Zhiyong Wang, http://orcid.org/0000-0003-3818-1073

Qizhi Tang, http://orcid.org/0009-0000-8674-7655

Xiaoling Cao, http://orcid.org/0000-0003-4993-8385

Chufen Chen, http://orcid.org/0000-0002-7148-2858

Yunxian Dong, http://orcid.org/0000-0002-7112-2369

Zhongye Xu, http://orcid.org/0000-0002-7551-0270

Dongming Lv, http://orcid.org/0000-0001-9642-0410

Yanchao Rong, http://orcid.org/ 0000-0001-9125-189X

Miao Chen, http://orcid.org/0000-0002-3538-8231

Bing Tang, http://orcid.org/0000-0001-5859-8250

Wuguo Deng, http://orcid.org/0000-0002-1193-1500

Jiayuan Zhu, http://orcid.org/0000-0003-1501-6999

Zhicheng Hu，http://orcid.org/0000-0002-0026-0676

Key words: diabetes, diabetic wound, exosomes, stem cell, apoptosis, endothelial cell

JACQUI FLETCHER OBE Clinical Editor, Wounds UK on behalf of the 4 Nations Stop the Pressure Team.

With thanks to:

The Society of Tissue Viability NWCSP, Pink Marketing, Tissue Viability colleagues from England, Northern Ireland, Scotland and Wales, Wounds UK, Journal of Wound Care, The Journal of Tissue Viability and our commercial colleagues